ArticleScientific reports2023

Use of Ranibizumab for evaluating focal laser combination therapy for refractory diabetic macular edema patients: an exploratory study on the RELAND trials.

Makoto Hatano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.